haloperidol has been researched along with angiotensin i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, SE; Cicila, GT; Katwa, LC; Lee, SJ; Tyagi, SC; Weber, KT | 1 |
| Ahokas, A; Nikkilä, H; Rimón, R; Wahlbeck, K | 1 |
2 other study(ies) available for haloperidol and angiotensin i
| Article | Year |
|---|---|
Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Aspartic Acid Endopeptidases; Cathepsin D; Cells, Cultured; Dexamethasone; Enzyme Inhibitors; Gene Expression; Haloperidol; Heart Valves; Lisinopril; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1996 |
Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients.
Topics: Acute Disease; Adult; Angiotensin I; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Immunity, Cellular; Lymphocytes; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; Psychotic Disorders; Sampling Studies; Schizophrenia; Therapeutic Equivalency | 2000 |